THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New enzyme treatment shows promise for rare blood disorder
Disease control Not yet recruitingThis study looks back at medical records of 94 people with a rare inherited blood disorder called cTTP. These people received a lab-made version of a missing enzyme (rADAMTS13) to prevent or treat dangerous blood clots. The goal is to see how the treatment affected their health, …
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
New study tracks Real-World safety of adzynma for rare blood disorder
Knowledge-focused Not yet recruitingThis study looks at the safety of a drug called Adzynma in people with a rare inherited blood disorder (cTTP) that causes dangerous blood clots. Researchers will review medical records of about 50 children and adults who have already received Adzynma in regular care. The main goa…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC